Ying-yi Li

发表

T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.

Chaofu Wang, Peng Zhang, Zhen Wang, 2013, Oncology reports.

Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis‐inducing ability

N. Mukaida, T. Baba, T. Taniguchi, 2010, International journal of cancer.

CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process.

K. Matsushima, N. Mukaida, T. Baba, 2009, Journal of immunology.

CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process1

K. Matsushima, N. Mukaida, T. Baba, 2008, The Journal of Immunology.

Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor Expression1

N. Mukaida, T. Baba, K. Kuno, 2008, The Journal of Immunology.

Expression through Enhanced Antiangiogenic Factor in Alkali-Induced Corneal Neovascularization Fractalkine / CX 3 CL 1-CX 3 CR 1 Interactions Protective

N. Mukaida, T. Baba, K. Kuno, 2008 .

FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7

Menghong Sun, C. Liang, Yu-Pan Bai, 2015, Cancer science.

Pim-3 Regulates Stemness of Pancreatic Cancer Cells via Activating STAT3 Signaling Pathway

Yi-feng Hou, Ting Li, Ying-yi Li, 2017, Journal of Cancer.

Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (review).

C. Liang, Ying-yi Li, 2014, Molecular medicine reports.

Tumor cell apoptosis induces tumor‐specific immunity in a CC chemokine receptor 1‐ and 5‐dependent manner in mice

S. Kaneko, K. Matsushima, N. Mukaida, 2008, Journal of leukocyte biology.

A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression

B. Liu, N. Mukaida, Xianjun Yu, 2013, Molecular Cancer Research.

Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice

N. Mukaida, Xiang Du, Chun-lei Zheng, 2012, PloS one.

Roles of Pim‐3, a novel survival kinase, in tumorigenesis

N. Mukaida, Ying-yi Li, Ying-Ying Wang, 2011, Cancer science.

miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells

C. Liang, Zhen Wang, Hong-yu Li, 2015, Tumor Biology.

Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma.

P. Winter, G. Giannelli, N. Mukaida, 2015, Cancer research.

Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.

N. Mukaida, Ying-yi Li, Ying-yi Li, 2014, World journal of gastroenterology.

Proto‐oncogene, Pim‐3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad‐mediated apoptosis

K. Tsuneyama, K. Omura, N. Mukaida, 2007, Cancer science.

Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.

Hiroshi Ishikura, N. Mukaida, H. Ishikura, 2006, Cancer research.

A single hepatitis B virus genome with a reporter allows the entire viral life cycle to be monitored in primary human hepatocytes

M. Honda, Takayoshi Shirasaki, E. Mizukoshi, 2022, Hepatology communications.

Gemcitabine-induced CXCL8 expression counteracts its actions by inducing tumor neovascularization.

N. Mukaida, S. Matsugo, T. Baba, 2015, Biochemical and biophysical research communications.

Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

B. Liu, B. Ping, Zhen Wang, 2014, Oncology reports.

Essential contribution of Ets‐1 to constitutive Pim‐3 expression in human pancreatic cancer cells

K. Tsuneyama, N. Mukaida, T. Baba, 2009, Cancer science.

Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.

Ying-jian Zhang, Zhen Wang, Xiangyuan Chen, 2016, Biochemical and biophysical research communications.

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine

Menghong Sun, N. Mukaida, Xianjun Yu, 2015, Oncotarget.

Hepatitis B Virus Utilizes a Retrograde Trafficking Route via the Trans-Golgi Network to Avoid Lysosomal Degradation

M. Honda, S. Hashimoto, Takayoshi Shirasaki, 2022, Cellular and molecular gastroenterology and hepatology.

Title Essential contribution of Ets-1 to constitutive Pim-3 expression in humanpancreatic cancer cells

K. Tsuneyama, N. Mukaida, T. Baba, 2017 .

Title Identification of a phenanthrene derivative as a potent anticancer drug withPim kinase inhibitory activity

N. Mukaida, T. Baba, T. Taniguchi, 2017 .

Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity

N. Mukaida, T. Baba, T. Taniguchi, 2012, Cancer science.

Pancreatic cancer: diagnosis and treatments

Hong-yu Li, Jiang Chen, Xiaozhong Guo, 2015, Tumor Biology.

Title Pathophysiological roles of Pim-3 kinase in pancreatic cancer developmentand progression

N. Mukaida, Ying-yi Li, Ying-Yi Mukaida, 2017 .

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors

M. Honda, T. Yamashita, Tetsuro Shimakami, 2023, Viruses.

Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene

C. Liang, Zhen Wang, X. Yao, 2015, Tumor Biology.

Errata

S. Kaneko, K. Matsushima, T. Baba, 2008, Journal of leukocyte biology.

Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.

B. Liu, Sheng-Shun Huang, Hong-yu Li, 2013, The Journal of surgical research.

T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.

Chaofu Wang, Peng Zhang, Zhen Wang, 2013, Oncology reports.